Tim3 binding to galectin-9 stimulates antimicrobial immunity

Journal of Experimental Medicine

Volumn 207, Issue 11, 2010, Pages 2343-2354

  Jayaraman, Pushpa ^a   Sada Ovalle, Isabel ^a,c   Beladi, Sarah ^a   Anderson, Ana C ^b   Dardalhon, Valerie ^b   Hotta, Chie ^b   Kuchroo, Vijay K ^b   Behar, Samuel M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ECALECTIN; IMMUNOGLOBULIN; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEIN TIM3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; CELL DEATH; CONTROLLED STUDY; CYTOKINE RELEASE; INNATE IMMUNITY; MACROPHAGE ACTIVATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; TH1 CELL; TUBERCULOSIS;

ANIMALS; CASPASE 1; GALECTINS; GENE EXPRESSION REGULATION; INFLAMMATION; INTERLEUKIN-1BETA; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MICE; MICE, KNOCKOUT; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, VIRUS; TH1 CELLS; TUBERCULOSIS;

EID: 78149322264     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20100687     Document Type: Article

References (44)

1. Bergsbaken, T., and B.T. Cookson. 2007. Macrophage activation redirects yersinia-infected host cell death from apoptosis to caspase-1-dependent pyroptosis. PLoS Pathog. 3:e161. doi:10.1371/journal.ppat.0030161
2. Bhattacharyya, S., R. Singla, A.B. Dey, and H.K. Prasad. 1999. Dichotomy of cytokine profiles in patients and high-risk healthy subjects exposed to tuberculosis. Infect. Immun. 67:5597-5603.
3. Cao, E., X. Zang, U.A. Ramagopal, A. Mukhopadhaya, A. Fedorov, E. Fedorov, W.D. Zencheck, J.W. Lary, J.L. Cole, H. Deng, et al. 2007. T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligand-binding surface. Immunity. 26:311-321. doi:10.1016/j.immuni.2007.01.016
4. Cooper, A.M., D.K. Dalton, T.A. Stewart, J.P. Griffin, D.G. Russell, and I.M. Orme. 1993. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 178:2243-2247. doi:10.1084/jem.178.6.2243 (Pubitemid 23344885)
5. Denis, M. 1991. Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell. Immunol. 132:150-157. doi:10.1016/0008-8749(91)90014-3
6. Divangahi, M., M. Chen, H. Gan, D. Desjardins, T.T. Hickman, D.M. Lee, S. Fortune, S.M. Behar, and H.G. Remold. 2009. Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat. Immunol. 10:899-906. doi:10.1038/ni.1758
7. Flynn, J.L. 1999. Why is IFN-gamma insufficient to control tuberculosis? Trends Microbiol. 7:477-478, author reply :478-479. doi:10.1016/S0966-842X(99) 01611-X
8. Flynn, J.L., and J. Chan. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19:93-129. doi:10.1146/annurev.immunol.19.1.93
9. Flynn, J.L., J. Chan, K.J. Triebold, D.K. Dalton, T.A. Stewart, and B.R. Bloom. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-2254. doi:10.1084/jem.178.6.2249
10. Fremond, C.M., D. Togbe, E. Doz, S. Rose, V. Vasseur, I. Maillet, M. Jacobs, B. Ryffel, and V.F. Quesniaux. 2007. IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection. J. Immunol. 179:1178-1189.
11. Golden-Mason, L., B.E. Palmer, N. Kassam, L. Townshend-Bulson, S. Livingston, B.J. McMahon, N. Castelblanco, V. Kuchroo, D.R. Gretch, and H.R. Rosen. 2009. Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells. J. Virol. 83:9122-9130. doi:10.1128/JVI.00639-09
12. Guan, Z., L.D. Baier, and A.R. Morrison. 1997. p38 mitogen-activated protein kinase down-regulates nitric oxide and up-regulates prostaglandin E2 biosynthesis stimulated by interleukin-1beta. J. Biol. Chem. 272:8083-8089. doi:10.1074/jbc.272.12.8083
13. Gutierrez, M.G., S.S. Master, S.B. Singh, G.A. Taylor, M.I. Colombo, and V. Deretic. 2004. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell. 119:753-766. doi:10.1016/j.cell.2004.11.038
14. Harris, J., J.C. Hope, and J. Keane. 2008. Tumor necrosis factor blockers influence macrophage responses to Mycobacterium tuberculosis. J. Infect. Dis. 198:1842-1850. doi:10.1086/593174
15. Imaizumi, T., M. Kumagai, N. Sasaki, H. Kurotaki, F. Mori, M. Seki, N. Nishi, K. Fujimoto, K. Tanji, T. Shibata, et al. 2002. Interferon-gamma stimulates the expression of galectin-9 in cultured human endothelial cells. J. Leukoc. Biol. 72:486-491.
16. Jones, R.B., L.C. Ndhlovu, J.D. Barbour, P.M. Sheth, A.R. Jha, B.R. Long, J.C. Wong, M. Satkunarajah, M. Schweneker, J.M. Chapman, et al. 2008. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J. Exp. Med. 205:2763-2779. doi:10.1084/jem.20081398
17. Juffermans, N.P., S. Florquin, L. Camoglio, A. Verbon, A.H. Kolk, P. Speelman, S.J. van Deventer, and T. van Der Poll. 2000. Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis. J. Infect. Dis. 182:902-908. doi:10.1086/315771
18. Kashio, Y., K. Nakamura, M.J. Abedin, M. Seki, N. Nishi, N. Yoshida, T. Nakamura, and M. Hirashima. 2003. Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway. J. Immunol. 170:3631-3636.
19. Kirschning, C.J., H. Wesche, T. Merrill Ayres, and M. Rothe. 1998. Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J. Exp. Med. 188:2091-2097. doi:10.1084/jem.188.11.2091
20. Koguchi, K., D.E. Anderson, L. Yang, K.C. O'Connor, V.K. Kuchroo, and D.A. Hafler. 2006. Dysregulated T cell expression of TIM3 in multiple sclerosis. J. Exp. Med. 203:1413-1418. doi:10.1084/jem.20060210
21. Koo, I.C., C. Wang, S. Raghavan, J.H. Morisaki, J.S. Cox, and E.J. Brown. 2008. ESX-1-dependent cytolysis in lysosome secretion and inflammasome activation during mycobacterial infection. Cell. Microbiol. 10:1866-1878. doi:10.1111/j.1462-5822.2008.01177.x
22. MacMicking, J.D., G.A. Taylor, and J.D. McKinney. 2003. Immune control of tuberculosis by IFN-gamma-inducible LRG-47. Science. 302:654-659. doi:10.1126/science.1088063
23. Mariathasan, S., and D.M. Monack. 2007. Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat. Rev. Immunol. 7:31-40. doi:10.1038/nri1997
24. Master, S.S., S.K. Rampini, A.S. Davis, C. Keller, S. Ehlers, B. Springer, G.S. Timmins, P. Sander, and V. Deretic. 2008. Mycobacterium tuberculosis prevents inflammasome activation. Cell Host Microbe. 3:224-232. doi:10.1016/j.chom.2008.03.003
25. Mayer-Barber, K.D., D.L. Barber, K. Shenderov, S.D. White, M.S. Wilson, A. Cheever, D. Kugler, S. Hieny, P. Caspar, G. Núñez, et al. 2010. Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo. J. Immunol. 184:3326-3330. doi:10.4049/jimmunol.0904189
26. Means, T.K., E. Lien, A. Yoshimura, S. Wang, D.T. Golenbock, and M.J. Fenton. 1999. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. J. Immunol. 163:6748-6755.
27. Monney, L., C.A. Sabatos, J.L. Gaglia, A. Ryu, H. Waldner, T. Chernova, S. Manning, E.A. Greenfield, A.J. Coyle, R.A. Sobel, et al. 2002. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature. 415:536-541. doi:10.1038/415536a
28. Sabatos, C.A., S. Chakravarti, E. Cha, A. Schubart, A. Sánchez-Fueyo, X.X. Zheng, A.J. Coyle, T.B. Strom, G.J. Freeman, and V.K. Kuchroo. 2003. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat. Immunol. 4:1102-1110. doi:10.1038/ni988
29. Sada-Ovalle, I., A. Chiba, A. Gonzales, M.B. Brenner, and S.M. Behar. 2008. Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria. PLoS Pathog. 4:e1000239. doi:10.1371/journal.ppat.1000239
30. Sánchez-Fueyo, A., J. Tian, D. Picarella, C. Domenig, X.X. Zheng, C.A. Sabatos, N. Manlongat, O. Bender, T. Kamradt, V.K. Kuchroo, et al. 2003. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat. Immunol. 4:1093-1101. doi:10.1038/ni987
31. Seki, M., S. Oomizu, K.M. Sakata, A. Sakata, T. Arikawa, K. Watanabe, K. Ito, K. Takeshita, T. Niki, N. Saita, et al. 2008. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin. Immunol. 127:78-88. doi:10.1016/j.clim.2008.01.006
32. Sugawara, I., H. Yamada, S. Hua, and S. Mizuno. 2001. Role of interleukin (IL)-1 type 1 receptor in mycobacterial infection. Microbiol. Immunol. 45:743-750.
33. Takii, T., T. Akahoshi, K. Kato, H. Hayashi, T. Marunouchi, and K. Onozaki. 1992. Interleukin-1 up-regulates transcription of its own receptor in a human fibroblast cell line TIG-1: role of endogenous PGE2 and cAmacrophage. Eur. J. Immunol. 22:1221-1227. doi:10.1002/eji.1830220517
34. Tetsuka, T., D. Daphna-Iken, S.K. Srivastava, L.D. Baier, J. DuMaine, and A.R. Morrison. 1994. Cross-talk between cyclooxygenase and nitric oxide pathways: prostaglandin E2 negatively modulates induction of nitric oxide synthase by interleukin 1. Proc. Natl. Acad. Sci. USA. 91:12168-12172. doi:10.1073/pnas.91.25.12168
35. Watanabe, Y., A. Namba, K. Honda, Y. Aida, H. Matsumura, O. Shimizu, N. Suzuki, N. Tanabe, and M. Maeno. 2009. IL-1beta stimulates the expression of prostaglandin receptor EP4 in human chondrocytes by increasing production of prostaglandin E2. Connect. Tissue Res. 50:186-193. doi:10.1080/03008200802588451
36. Weber, A., P. Wasiliew, and M. Kracht. 2010. Interleukin-1beta (IL-1beta) processing pathway. Sci. Signal. 3:cm2. doi:10.1126/scisignal.3105cm2
37. Woodworth, J.S., Y. Wu, and S.M. Behar. 2008. Mycobacterium tuberculosis-specific CD8+ T cells require perforin to kill target cells and provide protection in vivo. J. Immunol. 181:8595-8603.
38. Yamada, H., S. Mizumo, R. Horai, Y. Iwakura, and I. Sugawara. 2000. Protective role of interleukin-1 in mycobacterial infection in IL-1 alpha/beta double-knockout mice. Lab. Invest. 80:759-767. (Pubitemid 30340660)
39. Yang, R.B., M.R. Mark, A. Gray, A. Huang, M.H. Xie, M. Zhang, A. Goddard, W.I. Wood, A.L. Gurney, and P.J. Godowski. 1998. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature. 395:284-288. doi:10.1038/26239
40. Yang, L., D.E. Anderson, J. Kuchroo, and D.A. Hafler. 2008. Lack of TIM-3 immunoregulation in multiple sclerosis. J. Immunol. 180:4409-4414.
41. Yoshida, H., T. Imaizumi, M. Kumagai, K. Kimura, C. Satoh, N. Hanada, K. Fujimoto, N. Nishi, K. Tanji, T. Matsumiya, et al. 2001. Interleukin-1beta stimulates galectin-9 expression in human astrocytes. Neuroreport. 12:3755-3758. doi:10.1097/00001756-200112040-00030 (Pubitemid 33105165)
42. Yu, H.B., and B.B. Finlay. 2008. The caspase-1 inflammasome: a pilot of innate immune responses. Cell Host Microbe. 4:198-208. doi:10.1016/j.chom.2008. 08.007
43. Zhang, M., Y. Lin, D.V. Iyer, J. Gong, J.S. Abrams, and P.F. Barnes. 1995. T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect. Immun. 63:3231-3234.
44. Zhu, C., A.C. Anderson, A. Schubart, H. Xiong, J. Imitola, S.J. Khoury, X.X. Zheng, T.B. Strom, and V.K. Kuchroo. 2005. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat. Immunol. 6:1245-1252. doi:10.1038/ni1271